Should you microdose Ozempic? Experts are split on risks vs benefits

Trending 2 months ago

NEWYou tin now perceive to Fox News articles!

The emergence of GLP-1s (glucagon-like peptide-1 receptor agonists) has introduced caller approaches to some weight nonaccomplishment and wide metabolic health.

Some users person recovered that microdosing, aliases taking nan supplier successful mini amounts, achieves nan champion wellness outcomes, but immoderate experts pass against it.

In a erstwhile question and reply pinch Fox News Digital, Dr. Terry Dubrow, a integrative surgeon and TV characteristic based successful Newport Beach, California, recommended that everyone takes a debased regular dose, moreover if they don’t request to lose weight.

DOCTOR REVEALS SECRETS TO LASTING WEIGHT LOSS WITHOUT COUNTING CALORIES

"I americium obsessed pinch nan conception of microdosing," he said. "I deliberation possibly half nan starting dose for diabetes is nan measurement to spell — and you astir apt don't request it each 7 days, it's astir apt each 10 days, conscionable to benignant of modulate nan magnitude of sweetener successful nan blood."

Woman holding GLP-1 medications

Microdosing GLP-1s could beryllium much costly long-term, according to a bariatric surgeon. (iStock)

The attack has gained fame connected societal media, arsenic influencers and self-proclaimed "health gurus" person promoted it moreover for group without glucosuria aliases obesity.

In a caller section of nan Full Send podcast, Bryan Johnson, a task capitalist and online creator who intends to reverse aging and extend quality lifespan, shared that he microdoses Ozempic.

WHY MICRODOSING OZEMPIC COULD BECOME AS COMMON AS TAKING A MULTIVITAMIN

"There are immoderate broadside effects. For example, nan dose I'm connected raises my resting bosom rate by 2 aliases 3 beats, which is simply a large woody for me, but nan benefits are great," he said.

"GLP-1s are nan first legit longevity drug," he went on. "It’s an astonishing supplier … There’s conscionable thing that rivals its efficacy."

Hand holding GLP-1 injection pens

"It’s an astonishing supplier … There’s conscionable thing that rivals its efficacy," Bryan Johnson said astir Ozempic. (iStock)

Johnson suggested that a early wherever astir group are microdosing GLP-1s is "not excessively acold off."

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

"I americium arsenic patient arsenic a personification tin be, and I still use from GLP-1s," he said. "It has different metabolic effects, it has bully neuroprotective effects."

Despite these claims, immoderate weight-loss experts find this attack to beryllium not only much costly, but besides little effective.

Ozempic

One longevity guru suggested that a early wherever astir group are microdosing a GLP-1s is "not excessively acold off." (REUTERS/Hollie Adams/File Photo)

Dr. Andre Teixeira, a bariatric surgeon pinch nan Orlando Health Weight Loss and Bariatric Surgery Institute, told Fox News Digital that microdosing is "truly dependent" connected nan individual.

CLICK HERE FOR MORE HEALTH STORIES

"The interest is location is nary existent protocol for it," he said. "We do not do microdosing astatine our practice."

While immoderate group whitethorn deliberation microdosing is cheaper, nan expert claims it tin beryllium "more costly successful nan agelong run."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"[That's] because you’re adjusting nan dose and past not getting nan afloat benefits of nan medication," he said. "I spot group who get disappointment that they are not achieving nan weight-loss goal they were hoping for because they are spreading retired their doses."

"The consequence is that you’re not only playing pinch nan imaginable benefits, but you’re besides playing pinch nan broadside effects, for illustration nausea and vomiting."

The master recommends moving intimately pinch a healthcare supplier earlier starting a GLP-1. "I do not promote microdosing connected your own," he added.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Fox News Digital reached retired to GLP-1 drugmakers Novo Nordisk and Lilly for comment. 

Fox News Digital's Melissa Rudy contributed to this report.

Angelica Stabile is simply a manner newsman for Fox News Digital.

More
Source foxnews.com
foxnews.com